Skip to main content
Inhibrx, Inc. (INBX)
NASDAQ: INBX · IEX Real-Time Price · USD
34.70
+0.21 (0.61%)
At close: May 17, 2024, 4:00 PM
34.54
-0.16 (-0.46%)
After-hours: May 17, 2024, 5:15 PM EDT

Inhibrx Market Cap

Inhibrx has a market cap or net worth of $1.82 billion as of May 17, 2024. Its market cap has increased by 66.45% in one year.

Market Cap
1.82B
Enterprise Value
1.78B
1-Year Change
66.45%
Ranking
#2015
Category
Small-Cap
Stock Price
$34.70

Market Cap Chart

Since the IPO on August 19, 2020, Inhibrx's market cap has increased from $606.13M to $1.82B, an increase of 200.25%. That is a compound annual growth rate of 34.12%.

History

DateMarket Cap% Change
May 17, 20241.82B0.61%
May 16, 20241.81B0.34%
May 15, 20241.80B0.68%
May 14, 20241.79B0.26%
May 13, 20241.78B-0.70%
May 10, 20241.80B-1.15%
May 9, 20241.82B11.37%
May 8, 20241.63B0.15%
May 7, 20241.63B0.26%
May 6, 20241.63B0.44%
May 3, 20241.62B0.42%
May 2, 20241.61B-0.85%
May 1, 20241.63B0.77%
Apr 30, 20241.61B-0.35%
Apr 29, 20241.62B0.29%
Apr 26, 20241.61B-0.09%
Apr 25, 20241.62B-0.85%
Apr 24, 20241.63B0.74%
Apr 23, 20241.62B0.09%
Apr 22, 20241.62B-0.64%
Apr 19, 20241.63B-0.38%
Apr 18, 20241.63B-0.46%
Apr 17, 20241.64B-
Apr 16, 20241.64B-0.37%
Apr 15, 20241.65B-0.69%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Ginkgo Bioworks Holdings 1.88B
Protagonist Therapeutics 1.87B
Fusion Pharmaceuticals 1.83B
Ardelyx 1.83B
NewAmsterdam Pharma Company 1.82B
Addus HomeCare 1.81B
Veracyte 1.79B
Syndax Pharmaceuticals 1.78B
Market Cap Rankings